Methadone prescribing and COVID-19

FromThe Lancet Psychiatry in conversation with

Start listening View podcast show

Methadone prescribing and COVID-19

FromThe Lancet Psychiatry in conversation with

ratings:

Length:

14 minutes

Released:

Mar 24, 2020

Format:

Podcast episode

Description

Dustin Graham talks with Dr Ayana Jordan about recent COVID-19 related changes in the USA for prescribing medications to treat addiction Dustin Graham talks with Dr Ayana Jordan about recent COVID-19 related changes in the USA for prescribing medications to treat addiction.

Released:

Mar 24, 2020

Format:

Podcast episode

Titles in the series (95)

Dustin Graham, Senior Editor, speaks to the journal’s authors to explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Skip carousel

The Lancet Psychiatry: July 25, 2014 by The Lancet Psychiatry in conversation with
16 min listen
The Lancet Psychiatry: October 08, 2014 by The Lancet Psychiatry in conversation with
17 min listen
The Lancet Psychiatry: February 25, 2015 by The Lancet Psychiatry in conversation with
35 min listen
The Lancet Psychiatry: November 5, 2014 by The Lancet Psychiatry in conversation with
16 min listen
The Lancet Psychiatry: December 3, 2014 by The Lancet Psychiatry in conversation with
12 min listen
Hearing voices: The Lancet Psychiatry: March 11, 2015 by The Lancet Psychiatry in conversation with
15 min listen
Autism spectrum conditions: The Lancet Psychiatry, Oct 28, 2015 by The Lancet Psychiatry in conversation with
25 min listen
The Lancet Psychiatry: June 18, 2014 by The Lancet Psychiatry in conversation with
18 min listen
The Lancet Psychiatry: January 28, 2015 by The Lancet Psychiatry in conversation with
18 min listen
Women's Mental Health: The Lancet Psychiatry: November 14, 2016 by The Lancet Psychiatry in conversation with
14 min listen
The Lancet Psychiatry: May 02, 2014 by The Lancet Psychiatry in conversation with
21 min listen
Preventable harm: The Lancet Psychiatry: July 22, 2016 by The Lancet Psychiatry in conversation with
90 min listen
The Lancet Psychiatry: August 27, 2014 by The Lancet Psychiatry in conversation with
19 min listen
The Lancet Psychiatry: November 11, 2014 by The Lancet Psychiatry in conversation with
17 min listen
Medical marijuana laws: The Lancet Psychiatry: June 16, 2015 by The Lancet Psychiatry in conversation with
9 min listen
A history of self-harm: The Lancet Psychiatry: 26 April, 2017 by The Lancet Psychiatry in conversation with
18 min listen
Childhood bullying: The Lancet Psychiatry: October, 2015 by The Lancet Psychiatry in conversation with
10 min listen
Goths and self-harm: The Lancet Psychiatry: August 28, 2015 by The Lancet Psychiatry in conversation with
15 min listen
Smoking and psychosis: The Lancet Psychiatry: July 9, 2015 by The Lancet Psychiatry in conversation with
16 min listen
Emergency mental health care: The Lancet Psychiatry: May 27, 2015 by The Lancet Psychiatry in conversation with
8 min listen
The Lancet Psychiatry: Conference report: Schizophrenia International Research Society, Florence, 2–6 April, 2016 by The Lancet Psychiatry in conversation with
44 min listen
Suicide, homicide, and mental illness: The Lancet Psychiatry: Jan 2017 by The Lancet Psychiatry in conversation with
24 min listen
American Psychiatric Association 2016: The Lancet Psychiatry: May 24, 2016 by The Lancet Psychiatry in conversation with
57 min listen
Health of prison populations: The Lancet Psychiatry: April 22, 2015 by The Lancet Psychiatry in conversation with
18 min listen
A Commission is announced: The Lancet Psychiatry: December 11, 2016 by The Lancet Psychiatry in conversation with
6 min listen
Mental health in China and India: The Lancet and The Lancet Psychiatry: May 18, 2016 by The Lancet Psychiatry in conversation with
21 min listen
Predicting psychosis: The Lancet Psychiatry: November 16, 2015 by The Lancet Psychiatry in conversation with
19 min listen
Effectiveness of traditional healers: The Lancet Psychiatry : February 2016 by The Lancet Psychiatry in conversation with
18 min listen
Experimental medicine for mood disorders by The Lancet Psychiatry in conversation with
8 min listen
Making cannabis safer: The Lancet Psychiatry: March 1, 2017 by The Lancet Psychiatry in conversation with
17 min listen

More Episodes from The Lancet Psychiatry in conversation with

Skip carousel

Sebastian Wolf on exercise and mental health by The Lancet Psychiatry in conversation with
30 min listen
Jinah Park and Whanhee Lee on heat and emergency admissions by The Lancet Psychiatry in conversation with
24 min listen
Vincenzo Oliva on medications for psychotic depression by The Lancet Psychiatry in conversation with
24 min listen
Maike Richter and Nils Opel on narcissistic traits by The Lancet Psychiatry in conversation with
28 min listen
Lucy Stephenson, Astrid Gieselmann, and Matthé Scholten on self-binding directives by The Lancet Psychiatry in conversation with
38 min listen
Gustavo Medeiros on brain-based correlates of antidepressant response to ketamine by The Lancet Psychiatry in conversation with
31 min listen
Felicity Waite on psychological therapy for sleep problems in young people at risk of psychosis by The Lancet Psychiatry in conversation with
33 min listen
Joelle Mak and Ligia Kiss on psychosocial interventions for survivors of human trafficking by The Lancet Psychiatry in conversation with
27 min listen
Rory O’Connor on premature mortality in people with mental illness by The Lancet Psychiatry in conversation with
45 min listen
Ian Wong on methylphenidate for children and adolescents with ADHD by The Lancet Psychiatry in conversation with
16 min listen
Afarin Rahimi-Movaghar on drug use and treatment services in the Eastern Mediterranean by The Lancet Psychiatry in conversation with
20 min listen
Richard Morriss on cranial electrostimulation therapy for depression by The Lancet Psychiatry in conversation with
38 min listen
Protection or Paternalism? by The Lancet Psychiatry in conversation with
11 min listen
Wellcome Global Monitor by The Lancet Psychiatry in conversation with
6 min listen
Cultural Competency by The Lancet Psychiatry in conversation with
14 min listen
ECT safety by The Lancet Psychiatry in conversation with
21 min listen
Debbie Challis on helping children deal with the aftermath of COVID-19 by The Lancet Psychiatry in conversation with
14 min listen
Erica Crompton on the importance of first-person stories by The Lancet Psychiatry in conversation with
11 min listen
Michael Wright on mental health in Aboriginal communities by The Lancet Psychiatry in conversation with
34 min listen
Kimberly Sue on increasing access to buprenorphine by The Lancet Psychiatry in conversation with
12 min listen
Youth work environments by The Lancet Psychiatry in conversation with
11 min listen
Off-radar youth by The Lancet Psychiatry in conversation with
25 min listen
If a patient dies by suicide by The Lancet Psychiatry in conversation with
20 min listen
Life After Suicide by The Lancet Psychiatry in conversation with
18 min listen
Safe Injection Sites by The Lancet Psychiatry in conversation with
13 min listen
Psychological therapies in first-onset psychosis by The Lancet Psychiatry in conversation with
39 min listen
The Connection Coalition by The Lancet Psychiatry in conversation with
9 min listen
Active ingredients by The Lancet Psychiatry in conversation with
9 min listen
Rikers Island by The Lancet Psychiatry in conversation with
11 min listen
Digital psychiatry: filling in the gaps by The Lancet Psychiatry in conversation with
11 min listen

Related podcast episodes

Skip carousel

Old Drugs, New Disease by Chasing Life
12 min listen
What A New Antiviral Drug Could Mean For The Future Of COVID: The FDA's advisory panel has voted to recommend a new antiviral drug for COVID. What you need to know and how this treatment might change the pandemic. by Short Wave
14 min listen
Mifepristone–Science, Abortion Care, and Politics: The US Supreme Court will soon decide a case challenging the US Food and Drug Administration’s (FDA’s) approval of mifepristone. Author Holly Fernandez Lynch, JD, MBE, University of Pennsylvania, joins JAMA Executive Editor Gregory Curfman, MD, to... by JAMA Author Interviews
19 min listen
Diagnosis and Treatment of Opioid Use Disorder in Adolescence: Treatment with buprenorphine is approved and effective for adolescents with opioid use disorder (OUD) but is underused. JAMA Pediatrics Editor in Chief Dimitri Christakis, MD, and JAMA Pediatrics Associate Editor Alison A. Galbraith, MD, discuss... by JAMA Pediatrics Editors' Summary
19 min listen
Heroin: N'ganga Dimitri: Meet Dimitri, an evangelist for Ibogaine, the wonder-drug that kicked his heroin addiction. by Us & Them
35 min listen
Andrea Garcia, JD, MPH, shares vaccine updates on boosters and young children: AMA CXO Todd Unger talks with AMA's Director of Science, Medicine and Public Health, Andrea Garcia, about trending topics related to the pandemic over the past week. Also covering Pfizer's announcement regarding vaccine effectiveness in 5-11 year olds, the FDA's decision on booster shots, and a state-by-state look at swings in COVID case count. by AMA Update
13 min listen
A Deep Dive Into CBD For Endurance Athletes: Is It Beneficial And Effective? by The Time-Crunched Cyclist Podcast by CTS
79 min listen
Treatment of Hypertension in 2022: JAMA Interim Executive Editor Gregory Curfman, MD, interviews Robert M. Carey, MD, University of Virginia, about his review article on treatment of hypertension in the November 8, 2022, issue of JAMA. Their discussion addresses the clinical... by JAMA Cardiology Author Interviews
27 min listen
950. Bad News for Cereal Companies: The FDA has told cereal companies that they can no longer say their products are healthy. People have this idea that they’re making healthy choices when they eat cereal. This can’t be further from the truth and Dr. Martin says it’s a win for us!... by The Doctor Is In Podcast
31 min listen
Gabapentinoids - Gabapentin and Pregabalin: Tasce Bongiovanni, Donovan Maust and Nisha Iyer: Gabapentin is the 10th most prescribed drug in the United States and use is increasing. In 2002, 1% of adults were taking gabapentinoids (gabapentin and or pregabalin). By 2015 that number increased to 4% of US adults. There are a lot of... by GeriPal - A Geriatrics and Palliative Care Podcast
48 min listen
The Expanding Obesity Revolution: New Options: As many Americans start the summer stressed about their physiques and health, there are important developments. Drug-makers report successful mid-stage trials for oral compounds that could soon join the injectable prescription medication to treat obesi... by Conversations on Health Care
29 min listen
Overcoming COVID - August 22nd, Hour 3 by The Sean Hannity Show
27 min listen
Episode 12: The Rising Problem of Opioid Abuse: Prescription drug addiction, opioid abuse and overdose, narcan and what needs to happen. by 2 Docs Talk: The podcast about healthcare, the science of medicine and everything in between.
12 min listen
617. New Alzheimer’s Drug by The Doctor Is In Podcast
30 min listen
Cannabis and cannabinoids: Weighing the benefits and risks of use by psychiatric patients with Dr. Diana M. Martinez: Diana M. Martinez, MD, conducts a Masterclass on marijuana’s effects on psychiatric disorders. , a professor of psychiatry at Columbia University, New York, specializes in addiction research. She disclosed receiving medication (cannabis) from Tilray... by Psychcast
22 min listen
New Safety Concerns Identified After FDA Approval of One in Three Drugs: Nearly one in three drugs has a postmarket safety event, according to a study published earlier this month in JAMA. The study looked at 222 novel therapies approved between 2001 and 2010. We spoke to Nicholas Downing, clinical fellow in the Departmen... by The Bio Report
20 min listen
Treatment of Hypertension in 2022: JAMA Interim Executive Editor Gregory Curfman, MD, interviews Robert M. Carey, MD, University of Virginia, about his review article on treatment of hypertension in the November 8, 2022, issue of JAMA. Their discussion addresses the clinical... by JAMA Clinical Reviews
27 min listen
Anxiety and Depression Symptoms After the Dobbs Abortion Rights Decision: Following the Dobbs decision, females aged 18-45 years living in states with “trigger laws” that restricted access to abortion reported a greater increase in symptoms of anxiety and depression than those in states without trigger laws. JAMA... by JAMA Author Interviews
14 min listen
The Future of Ob-Gyn Training in the US Post-Dobbs: An estimated 45% of accredited US obstetrics and gynecology residency programs are located in states that currently ban or severely restrict abortions. JAMA Associate Editor Linda Brubaker, MD, and JAMA Internal Medicine Deputy Editor Deborah Grady,... by JAMA Clinical Reviews
32 min listen
Life With The Fast Strains by What A Day
18 min listen
What’s Driving the Booming Market for Orphan Drugs: The market for Orphan drugs is growing at more than twice the rate of other prescription medicines In 2013, a record 260 therapeutics won orphan designations in the United States alone as science, policy, and pricing are fueling the trend for drugmak... by The Bio Report
18 min listen
Episode 129: Not Out of the Woods Yet by Osterholm Update
20 min listen
Vaccine progress for kids under 5 & more with Andrea Garcia, JD, MPH: AMA CXO Todd Unger discusses the latest on COVID vaccines for fall with AMA Director of Science, Medicine and Public Health Andrea Garcia, JD, MPH. Also covering the vaccine rollout for kids under 5, as well as AMA's statements on the U.S. Supreme Court decisions regarding firearm violence and overturning Roe v. Wade. by AMA Update
11 min listen
Sawbones: The Abortion Pill: Mifepristone, known colloquially as the abortion pill, has recently been in the news as its future availability in the United States comes into question. Dr. Sydnee and Justin go through the history of the medicine, from how it was discovered to how it was approved to what happened over the summer to change that. Music: "Medicines" by The Taxpayers https://taxpayers.bandcamp.com/ by Sawbones: A Marital Tour of Misguided Medicine
44 min listen
Sawbones: Patents vs. Life-Saving Drugs: John Green recently made a video asking Johnson & Johnson not to extend their patent on a tuberculosis drug, which would keep it exclusive and expensive. Dr. Sydnee and Justin talk about how drug patents work, the recent (good) update about bedaquiline specifically, and the next steps that pharmaceutical companies and the government need to make to keep life-saving drugs affordable. We’re back to classic Sawbones, keeping tabs on Big Pharma again. Music: "Medicines" by The Taxpayers https://taxpayers.bandcamp.com/ by Sawbones: A Marital Tour of Misguided Medicine
39 min listen
Weekly Infusion 03 Candy Finnigan: Great minds think alike on Weekly Infusion, addiction specialists Dr. Drew and Dr. Bruce are joined by Candy Finnigan, star of A&E's, Intervention. Candy was one of the very first women to become an interventionist. The threesome discusses... by Weekly Infusion
43 min listen
GUILTY: Dentist 'Sleepovers' With Beauty Queen Ends in Murder by Crime Stories with Nancy Grace
41 min listen
Herb and Drug Interactions: The practice of medicine is now at a crossroad. Countless patients are being treated simultaneously with both Western and Oriental medicine. by Sharon Kleyne Hour
56 min listen
Encore Herb and Drug Interactions: The practice of medicine is now at a crossroad. Countless patients are being treated simultaneously with both Western and Oriental medicine. It is quite common for a patient to seek herbal treatments while taking several prescription medications. by Sharon Kleyne Hour
56 min listen
160: CBD & Cannabis: Stigma vs. Science – Janice Bissex: As more people turn to cannabis and CBD for their medicinal properties, it’s important to learn about the history and the science behind these products in order to better understand the myths and stigma surrounding them. by Sound Bites A Nutrition Podcast
54 min listen

Discover this podcast and so much more

Methadone prescribing and COVID-19

Methadone prescribing and COVID-19

Description

Titles in the series (95)

More Episodes from The Lancet Psychiatry in conversation with

Related podcast episodes